Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/898437/000117184318007138/f8k_102418.htm
November 2022
November 2022
August 2022
June 2022
May 2022
March 2022
November 2021
November 2021
November 2021
August 2021
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/898437/000117184318007138/f8k_102418.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Anika Therapeutics, Inc..
Anika Therapeutics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Ticker: ANIKEvents:
CIK: 898437
Form Type: 8-K Corporate News
Accession Number: 0001171843-18-007138
Submitted to the SEC: Wed Oct 24 2018 8:30:23 AM EST
Accepted by the SEC: Wed Oct 24 2018
Period: Tuesday, October 23, 2018
Industry: Surgical And Medical Instruments And Apparatus